Global CAR T Cell Therapy Market Forecast to 2024-2035 The latest drafted document on the global CAR T Cell Therapy Market by Roots Analysis, provides a brief discussion on industry size, current growth scenario and future opportunities. In the market study report, our authors extensively covered qualitative and quantitative analysis including investment opportunities to help stakeholders in...

Cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact, conventional cancer treatments, such as chemotherapy, surgery and radiation therapy, have demonstrated very limited efficacy in late-stage cancers. The global CAR T-cell therapy market size is projected to grow from USD 4.6...

"Global Demand Outlook for Executive Summary Cell-Based Immunotherapy Market Size and Share CAGR Value The cell-based immunotherapy market is expected to witness market growth at a rate of 19.01% in the forecast period of 2021 to 2028. Cell-Based Immunotherapy Market report supports businesses to thrive in the market by providing them with an array of insights about the market and...

Market Overview The global anti-crease agent market was valued at USD 782.8 million in 2021 and is expected to reach USD 1,203.6 million by 2030, growing at a CAGR of 5.1%. Anti-crease agents, a critical segment of textile finishing agents, are used to enhance the wrinkle resistance, durability, and aesthetic appeal of fabrics. As consumer demand...

The global gout therapeutics market is poised for significant expansion over the next decade. Valued at USD 3.13 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2034, reaching USD 6.15 billion by 2034. The increasing prevalence of gout, advancements in therapeutic options, and heightened awareness of...

Cell and Gene Therapy Market Overview The Global Cell and Gene Therapy Market is witnessing rapid expansion, driven by breakthroughs in regenerative medicine, rising prevalence of chronic and genetic disorders, and increasing investments in advanced therapeutic research. Valued at USD 41.3 billion in 2025, the market is projected to reach USD 143.2 billion by 2033, growing at a...